SS
ZBIO

SBI Securities’s Zenas BioPharma ZBIO Stock Holding History

SBI Securities’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20
Closed -$391 – 4231
2026
Q1 		$391 Buy
+20
New +$449 ﹤0.01% 2980
2025
Q4 		– Sell
-1
Closed -$22 – 4269
2025
Q3 		$22 Buy
+1
New +$16 ﹤0.01% 3901
2025
Q1 		– Sell
-2
Closed -$16 – 4222
2024
Q4 		$16 Buy
+2
New +$31 ﹤0.01% 3877

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SBI Securities's ZBIO Position: Q2 2026 in Review

SBI Securities sold out of Zenas BioPharma (ZBIO) in Q2 2026, closing a stake of 20 shares — an estimated $391 sold.

SBI Securities first reported a position in ZBIO in Q4 2024 and held it in 3 quarters. The position peaked at $391 in Q1 2026. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • SBI Securities reported no remaining Zenas BioPharma position as of Q2 2026 after selling out during the quarter.
  • SBI Securities sold 20 Zenas BioPharma shares in Q2 2026, an estimated $391.
  • SBI Securities first reported a position in Zenas BioPharma in Q4 2024 and held it in 3 quarters.
  • SBI Securities's Zenas BioPharma position peaked at $391 in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.